The genetic testing market is however not devoid of challenges. Factors such as cost and the level of authenticity engaged in screening and detecting methods employed by physicians remain questionable. As each individual's genetic structure differs so do preferences, there is a need to develop a method that can be customized as per individual needs. Another challenge that the industry faces is the urgent need to employ standard regulations with regard to procedures employed during the genetic testing process.
Genetic testing market is highly competitive with several players vying for the market pie. The influx of new players into the lucrative market is further intensifying market competition. Key players profiled in report include Abbott Molecular Inc., Applied Biosystems Inc., AutoGenomics Inc., BioRad Laboratories, Celera Group, Clinical Data, Inc., Genzyme Genetics, Orchid Cellmark, Inc., PerkinElmer Inc., Quest Diagnostics Inc., Roche Diagnostics, Corp., Roche Molecular Diagnostics Inc. and Sciona Ltd.
The report titled "Genetic Testing: A Global Strategic Business Report" published by Global Industry Analysts, Inc. presents comprehensive analyses of major markets including the US, Canada, Japan, Europe and Rest of World. The report offers incisive insights into the economic fundamentals of the industry, market drivers, and trends, in addition to outlining the competitive landscape. Analysis is provided in US$ million for the period 2000-2015. The US market is further analyzed by the following segments - Pharmacogenomic Testing, Prenatal and Newborn Genetic Testing, and Predictive Medicine.
Copyright©2008 Vocus, Inc.
All rights reserved